The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis
Open accessAbstract
Iron demand in bone marrow increases when erythropoiesis is stimulated by hypoxia via increased erythropoietin (EPO) synthesis in kidney and liver. Hepcidin, a small polypeptide produced by hepatocytes, plays a central role in regulating iron uptake by promoting internalization and degradation of ferroportin, the only known cellular iron exporter. Hypoxia suppresses hepcidin, thereby enhancing intestinal iron uptake and release from internal stores. While HIF, a central mediator of cellular adaptation to hypoxia, directly regulates renal and hepatic EPO synthesis under hypoxia, the molecular basis of hypoxia/HIF-mediated hepcidin suppression in the liver remains unclear. Here, we used a genetic approach to disengage HIF activation from EPO synthesis and found that HIF-mediated suppression of the hepcidin gene (Hamp1) required EPO induction. EPO induction was associated with increased erythropoietic activity and elevated serum levels of growth differentiation factor 15. When erythropoiesis was inhibited pharmacologically, Hamp1 was no longer suppressed despite profound elevations in serum EPO, indicating that EPO by itself is not directly involved in Hamp1 regulation. Taken together, we provide in vivo evidence that Hamp1 suppression by the HIF pathway occurs indirectly through stimulation of EPO-induced erythropoiesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies in humans receiving recombinant EPO have not yet shown a significant inverse relationship between serum hepcidin and GDF15 levels”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [208]
In the citing paper
“Hepcidin suppression under conditions of hypoxia and hepatic HIF activation was dependent on erythropoietic activity in the bone marrow.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [208]
In the citing paper
“We found that recombinant murine GDF15 suppressed hepcidin in Hep3B cells at a concentration of 750 pg/ml.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [208]
In the citing paper
“found that hypoxia/HIF-mediated suppression of hepcidin required EPO.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [208]
In the citing paper
“However, we determined that the induction of EPO synthesis alone was not sufficient to suppress hepcidin in this model.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [208]
In the citing paper
“The latter, however, is most likely a reflection of increased erythropoietic activity.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [208]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251 · cited 6×
“The activity of HIF is controlled by O 2 -, iron, and ascorbate-dependent dioxygenases, also known as prolyl-hydroxy-lase domain–containing proteins 1–3 (PHD1–3), which use 2-oxo-glutarate as substrate for the hydroxylation of specific proline residues in HIF-α .”
InfluentialSimplified mammalian DNA isolation procedure
Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. J. M. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,497
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“…transferrin receptor 1 (TRFC) and transferrin receptor 2 (TFR2) (2, 11, 12), or hemojuvelin (HJV), which acts as a coreceptor for bone morphogenetic protein 6 (BMP6), increases hepcidin expression in a mothers against decapen-taplegic homolog–dependent (SMAD-dependent) fashion (13–15).”
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854
Ruzankina, Y., Pinzon‐Guzman, C., Asare, A., Ong, T., Pontano, L. L., Cotsarelis, G., Zediak, V. P., Velez, M., Bhandoola, A., & Brown, E. J. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.03.002 · Cited by 803
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
Andriopoulos Jr, B., Corradini, E., Xia, Y., Faasse, S. A., Chen, S., Grgurevic, L., Knutson, M. D., Pietrangelo, A., Vukicevic, S., Lin, H. Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.335 · Cited by 769
High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
Schödel, J., Oikonomopoulos, S., Ragoussis, J., Pugh, C. W., Ratcliffe, P. J., & Mole, D. R. (2011) · Blood · doi:10.1182/blood-2010-10-314427 · Cited by 724
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31370 · Cited by 639
Self-citationForging a field: the golden age of iron biology.
Andrews, N. C. (2008) · Blood · doi:10.1182/blood-2007-12-077388 · Cited by 623
Research works printed but not linked: 2
- Tanno, 2010, Curr Opin Hematol., 17, 184
- Hickey, 2007, J Clin Invest., 12, 3879
Cited by
Sorted by citations
Items 301–328 of 328
Weiss, M. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732587239.793577754
The Mechanism of HIF-PHI in the Treatment of Renal Anemia and the Research Progress of Roxadustat
王, 加. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.126853
Alfaro-Magallanes, V. M. (2022) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.71841
HIF-PH-Inhibitoren in der Therapie der renalen Anämie
Schröppel, B. (2022) · Dialyse aktuell · doi:10.1055/a-1924-3492
Anemia on Chronic Kidney Disease: The Role of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors
Riani, N. W. A., & Widiana, I. G. R. (2022) · Intisari Sains Medis · doi:10.15562/ism.v13i3.1545
Early Clinical Efficacy Study of Roxadustat in the Treatment of Patients with Renal Anemia
王, 加. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12121638
Prolylhydroxylaseinhibitoren – „new kids in the blood“
Grampp, S., & Schödel, J. (2023) · Die Nephrologie · doi:10.1007/s11560-023-00635-9
Isolated ACTH deficiency: an uncommon cause of hyperferritinaemia
Isoda, A., Saito, A., Matsumoto, M., & Sawamura, M. (2023) · BMJ Case Reports · doi:10.1136/bcr-2023-256049
Noulsri, E., & Lerdwana, S. (2024) · Medical Hypotheses · doi:10.1016/j.mehy.2024.111395
The Fight for Iron: A Central Theme in Host-Pathogen Interactions
Hamad, M. A. (2025) · Springer eBooks · doi:10.1007/978-981-96-1305-2_11
Iron Deficiency and Poor Cognition in Children
Hamad, M. A., & Abdelhaq, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-40858-8_340-1
Punia, R., & Goel, G. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01556
Murashima, M., Suzuki, K., Kasugai, T., Miyaguchi, Y., Hiratsuka, M., Tomonari, T., Ono, M., Mizuno, M., Tanaka, T., & Hamano, T. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70189
Predictive value of hepcidin and HIF1α protein levels for iron deposition in β-thalassemia
Cao, Y., & Luo, J. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-06644-1
Yang, L., Luo, Z., Wang, S., Lin, J., Chen, Y., & Wu, Y. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112340
Hepсidin regulation of adaptive immune cell functions
Orlova, E. G., Gorbunova, O. L., & Loginova, N. P. (2025) · Perm Medical Journal · doi:10.17816/pmj4265-19
Surcharges en fer rares d’origine génétique : caractérisation clinique, fonctionnelle, et biologique
Bardou‐Jacquet, E. (2013) · theses.fr (ABES) · doi:10.70675/99eb557fz5edcz4fdezbd26z84ca08eab5aa
La sérotonine intestinale : un acteur essentiel de la régulation de l'homéostasie du fer
Falabrègue, M. (2020) · theses.fr (ABES) · doi:10.70675/911bf09czfa11z4227zacfaz2f72ec7a7582
Le rôle de l'érythroferrone dans la régulation du métabolisme du fer
Sardo, U. (2020) · theses.fr (ABES) · doi:10.70675/d03e67aczc44bz4af9z8fa1zef080668f44f
Regulation of iron metabolism and its implications in cancer and metabolic disease
Park, J., Ying, W., & Lim, W. (2026) · KOBRA Reports · doi:10.64066/kobrareports.26.0010
Fangyu, Y., & Shuangquan, K. (2026) · Kidney Medicine · doi:10.1016/j.xkme.2026.101472
Emerging Therapies for Anemia in Chronic Kidney Disease: An Updated Review
Rahman, A. K. M. S., & Karim, M. M. (2026) · Haematology Journal of Bangladesh · doi:10.37545/haematoljbd2026173
Regulation of erythroid development by iron metabolism
Ishfaq, M., & Yien, Y. Y. (2026) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2026.06.005
Could Hepcidin Be a Phenotype-Related Biomarker in Patients with Stable Bronchiectasis?
Yilmaz, G., Çoban, H., Erel, F., Akış, M., Sarıoğlu, N., Colak, M., Şenel, M. Y., & Elmalı, A. D. M. (2026) · Life · doi:10.3390/life16091439
The Red Blood Cell–Liver Axis: A New Framework for Iron Homeostasis and Liver Biology
Mueller, S. (2026) · Biology · doi:10.3390/biology15191773
Metadata
- Authors
- Liu, Q., Davidoff, O., Niss, K., & Haase, V. H.
- Affiliations
- Vanderbilt University (US)
- MilliporeSigma (United States) (US)
- Corresponding author
- Haase, Volker H.
- ORCID
- Haase, Volker H.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-11-01
- Volume
- 122
- Issue
- 12
- Pages
- 4635-4644
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3533545
- OpenAlex
- W2002549547
- Cited by
- 328
- References
- 51
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 18 · 2023: 26 · 2022: 40 · 2021: 25 · 2020: 28 · 2019: 19 · 2018: 22 · 2017: 28 · 2016: 28 · 2015: 20 · 2014: 29 · 2013: 16
- FWCI
- 13.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R01-DK080821)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK080821, R01DK081646, P30DK020593)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- hypoxia-inducible factor, hepcidin, erythropoietin, erythropoiesis, iron metabolism, ferroportin, growth differentiation factor 15, hypoxia, iron absorption, liver
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Erythropoiesis, Erythropoietin, Gene Expression Regulation, Humans, Liver, Procollagen-Proline Dioxygenase, Gene Expression, Mice, Knockout, Hepatocytes, Antimicrobial Cationic Peptides, Cell Line, Tumor, Mice, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit, Growth Differentiation Factor 15, Hepcidins, Hypoxia-Inducible Factor-Proline Dioxygenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
